Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

Study ID: NCT06692894
Start Date: 2024-11-05
End Date: 2027-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Observational

Sponsor

University of Vermont

Source: clinicaltrials.gov

Share:
Add to list

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

Study ID: NCT06082960
Start Date: 2023-10-09
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase1

No. of Participants

120

Intervention / Treatment

GS-9911

Zimberelimab

Sponsor

Gilead Sciences

Source: clinicaltrials.gov

Share:
Add to list

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

Study ID: NCT05756660
Start Date: 2023-03-01
End Date: 2027-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

33

Intervention / Treatment

Sodium Thiosulfate

Sponsor

Children's Hospital Medical Center, Cincinnati

Source: clinicaltrials.gov

Share:
Add to list

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

Study ID: NCT05627960
Start Date: 2022-02-14
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase1

No. of Participants

77

Intervention / Treatment

AG-01 Compound

Sponsor

A&G Pharmaceutical Inc.

Source: clinicaltrials.gov

Share:
Add to list

Tribally Engaged Approaches to Lung Screening (TEALS)

Study ID: NCT04948060
Start Date: 2022-01-01
End Date: 2025-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

480

Intervention / Treatment

Enhanced lung cancer screening services

Sponsor

University of Oklahoma

Source: clinicaltrials.gov

Share:
Add to list

PC001- A Study to Evaluate the Usability of PointCheck

Study ID: NCT04448301
Start Date: 2021-02-09
End Date: 2025-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

PointCheck

Sponsor

Leuko Labs, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Study ID: NCT06235801
Start Date: 2024-05-22
End Date: 2029-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Gillter

Momothy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Study ID: NCT04054167
Start Date: 2019-06-14
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Low Dose Radiation Therapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study ID: NCT06082167
Start Date: 2024-06-07
End Date: 2029-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

600

Intervention / Treatment

Zantal

Zanzalintinib-matched Placebo

Pembrolizumab

Sponsor

EXELAXIS

Source: clinicaltrials.gov

Share:
Add to list

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

Study ID: NCT06521567
Start Date: 2025-03-06
End Date: 2032-01-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

95

Intervention / Treatment

Cobolimab

Supplied

Sponsor

GlaxoSmithKline

Source: clinicaltrials.gov

Share:
Add to list